Floatz logo

Therapeutic Asset Ratings

424 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
DROPERIDOL
Urinary Bladder Neoplasms
RenJi HospitalP4BB (65)
FENTANYL
Fractures, Bone
RenJi HospitalP4BB (65)
FENTANYL
Kidney Neoplasms
RenJi HospitalP4BB (65)
FENTANYL
Osteoarthropathy
RenJi HospitalP4BB (65)
FENTANYL
Rectal Neoplasms
RenJi HospitalP4BB (65)
FENTANYL
Sigmoid Neoplasms
RenJi HospitalP4BB (65)
FENTANYL
Urinary Bladder Neoplasms
RenJi HospitalP4BB (65)
Liraglutide
Disorder of Glucose Regulation
RenJi HospitalP3BB (64)
Irinotecan
Locally Advanced Pancreatic Cancer
RenJi HospitalP2/3BB (64)
DROPERIDOL
Colonic Neoplasms
RenJi HospitalP4B (62)
DROPERIDOL
Gynecologic Cancer
RenJi HospitalP4B (62)
DROPERIDOL
Liver Neoplasms
RenJi HospitalP4B (62)
DROPERIDOL
Stomach Neoplasms
RenJi HospitalP4B (62)
FENTANYL
Colonic Neoplasms
RenJi HospitalP4B (62)
FENTANYL
Gynecologic Cancer
RenJi HospitalP4B (62)
FENTANYL
Liver Neoplasms
RenJi HospitalP4B (62)
FENTANYL
Stomach Neoplasms
RenJi HospitalP4B (62)
Losartan
Obesity
RenJi HospitalP4B (61)
Denosumab
Bone Diseases
RenJi HospitalP3B (60)
Docetaxel
Carcinoma, Invasive Ductal, Breast
RenJi HospitalP3B (60)
Docetaxel
Mucinous Breast Cancer
RenJi HospitalP3B (60)
Docetaxel
Tubular Breast Cancer
RenJi HospitalP3B (60)
Epirubicin
Hepatic Portal Vein Tumor Invasion
RenJi HospitalP3B (60)
Narlumosbart
Bone Diseases
RenJi HospitalP3B (60)
Toripalimab
Clear Cell Renal Carcinoma
RenJi HospitalP2B (60)
Showing 26 to 50 of 424 assets
PreviousPage 2 of 17Next